Navigation Links
6th Annual International Translational Medicine Symposium held at Penn
Date:10/4/2011

PHILADELPHIA -- A unique gathering of international experts will be charting the unfolding landscape of how to bring personalized medicines to the consumer. Thought leaders from academic medical centers, government, and industry will identify opportunities and hazards about using personal genomic information to develop new treatments and cures. Held at the Perelman School of Medicine at the University of Pennsylvania on October 18 and 19, the 6th Annual Institute for Translational Medicine and Therapeutics (ITMAT) International Symposium, Translational Strategies in Contemporary Science, brings together a distinguished faculty of over two dozen international thought leaders who will discuss the present and future of translational medicine, including personalized genomics and disease risk; nature vs. nurture and epigenetics in personalized medicine; and recent drug-development models that work.

WHAT:

Talks will cover:

The promise of how personal genomes can lead to better drug response and disease-risk assessment and how environmental factors such as diet limit that promise.

Innovative approaches of academic-based research that are upending large Pharma's traditional role as the primary developer of new drugs.

A new collaborative model of drug discovery that is moving away from a single, private company to teams built from academia and the pharmaceutical and biotech industries.

WHO:

Garret A. FitzGerald, MD, Robert L. McNeil, Jr., Professor of Translational Medicine and Therapeutics, Chair of Department of Pharmacology, Director of ITMAT and Perelman School of Medicine, University of Pennsylvania (Conference Organizer)

Over 30 thought leaders in translational medicine will participate as speakers and panelists.

Among the Highlights

Day 1

As access to personal genomic information becomes more widespread, is there more to understanding disease risk and response than simply knowing your genome? Hear from speakers with two different perspectives on this issue:

Isaac S. Kohane, MD, PhD, Lawrence J. Henderson Professor of Health Sciences and Technology, Director of the Countway Library of Medicine, Co-Director of the Center for Biomedical Informatics, Harvard Medical School; and Director, i2b2 National Center for Biomedical Computing -- Overcoming the Incidentalome for a Responsible Genomic Medicine

Jun Wang, PhD, Executive Director of BGI (formerly known as Beijing Genomics Institute) -- Sequencing, Sequencing and Sequencing

Jeremy K. Nicholson, PhD, FRSC, FRCPath, FMedSci, Head of Department of Surgery and Cancer, Imperial College London, UK - Systems Medicine and Patient Journey Phenotyping

Day 2

What happens when genome meets environment? Learn more about the landscape that is so critical for the progression of personalized medicine:

Shelley L. Berger, PhD, Daniel S. Och University Professor, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania -- The Epigenetic Regulation of the Genome

Day 2

How can we fix the current drug development crisis? And what role can academia play? Learn about the traditional and new academic models for drug development from the people who have made them work:

Carl June, MD, Professor of Pathology and Laboratory Medicine, and Program Director for Translational Research in the Abramson Family Cancer Research Institute -- Synthetic Biology with Engineered T Cells

Joseph Schlessinger, PhD, William H. Prusoff Professor and Chair of Pharmacology, Yale University School of Medicine - Cell Signaling by Receptor Tyrosine Kinases; from Basic Principles to Cancer Therapy

Peter J. Ratcliffe, MD, FRCP, FMedSci, FRS, Nuffield Professor of Medicine and Head of Department, Nuffield Department of Clinical Medicine, University of Oxford - Drug Target Discovery in Academia

WHERE:

Perelman School of Medicine, University of Pennsylvania
Biomedical Research Building II/III
Auditorium and Lobby
421 Curie Boulevard, Philadelphia, PA 19104

WHEN:

Tuesday and Wednesday, October 18-19, 2011

MORE INFO:

More information, including the full agenda, is available online: http://www.itmat.upenn.edu/symposium.shtml

CAN'T ATTEND?

For members of the media not able to attend, we will be webcasting the entire conference and providing a limited number of private conference calls with panelists after their sessions.


'/>"/>
Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Media advisory: 2011 AAPS Annual Meeting and Exposition
2. Annual Breast Exams, Mammograms Still Key to Detecting Breast Cancer
3. Media registration opens for 2011 ASTRO Annual Meeting
4. Annual Pap Tests Often Ordered But Unneeded: Study
5. Annual cervical cancer screening persists, despite recommended guidelines
6. 2011 AAPS Annual Meeting and Exposition
7. Heart Disease Prevention May Save Billions Annually in U.S.
8. Largest Ob/Gyn Group Backs Annual Mammograms in 40s
9. ACR, SBI support updated ACOG recommendations that women begin annual mammograms at age 40
10. Sociologists to explore social conflict at annual meeting in Las Vegas, Aug. 20-23
11. More Than 200,000 Suffer Cardiac Arrest in Hospitals Annually
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating ... communities, 16 more public health departments have been awarded national accreditation through the ... million people into the expanding network of communities across the nation whose health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is ... making a huge impact on businesses and individual consumers alike. Laboratories can maximize ... have a value anywhere from $4 trillion to $11 trillion dollars by the year ...
(Date:3/23/2017)... , ... March 23, 2017 ... ... financial services firm serving the families and businesses of the Norwalk and ... program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... India , March 24, 2017 A ... market has been growing rapidly as the global sales of Adcetris ... the growth in the antibody drug conjugates market is driven by ... of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly and ... plans to invest $850 million in its U.S. ... across its U.S. enterprise, including research laboratories, manufacturing ... are being driven by demand for Lilly products, ... medicines in development targeting cancer, pain, diabetes and ...
Breaking Medicine Technology: